Exploring the Growth and Challenges of Aurora Cannabis Inc: A Comprehensive Analysis
LOS ANGELES– Aurora Cannabis Inc, the Canadian company that is paving the way for the cannabis industry, has announced the launch of a new program that aims to support and empower cannabis patients in their wellness journey. The program, called the Strainprint® App, is an award-winning journal that allows Aurora patients to track their medical cannabis journey and understand which strains, THC and CBD levels, ingestion methods, and doses work best for them.
The Strainprint App is designed to work in conjunction with the advice of healthcare professionals to provide patients with a comprehensive understanding of their cannabis usage. Patients can log their symptoms and consumption habits, explore new products, and learn more about strains to better manage their condition. All data entered and gathered by the app is anonymous and aggregated.
“We take a patient-first approach to cannabis and are proud to provide our patients with programs that improve their lives and their medical cannabis journey,” said Mike Jones, Senior Vice President of Medical at Aurora Cannabis. “By working with Strainprint, we can support our patients every step of the way, and further Aurora’s promise to prioritize patient well-being and provide the highest quality products.”
The launch of this program demonstrates Aurora’s commitment to the health and well-being of its patients. Through the Strainprint App, Aurora is not only providing patients with a tool to manage their condition, but also with access to information and resources that can enhance their overall quality of life. As a leading company in the cannabis industry, Aurora is setting the standard for patient care and demonstrating its dedication to advancing the field of medical cannabis.
Latest News
California’s Legal Cannabis Market Faces Declining Sales in Q1 2023
LOS ANGELES- California's legal cannabis market continues to grapple with challenges, as indicated by the latest tax and sales numbers released by the state's Department of Tax and Fee Administration. According to the agency's report ...
Organigram Enters Partnership with Phylos Bioscience to Enhance Cannabis Genetics and Technical Capabilities
LOS ANGELES-- Organigram Holdings Inc, a licensed producer of cannabis, announced today that it has forged a comprehensive technical and commercial relationship with Phylos Bioscience Inc., a renowned U.S. cannabis genetics company based in Portland, ...
Uncertain Future for Medical Cannabis Expansion in Texas as Legislative Session Nears Conclusion
AUSTIN-- As the Texas legislative session draws to a close this Memorial Day, the future of medical cannabis expansion in the state remains uncertain. Crucial legislation aimed at broadening access to low-THC medical cannabis products ...